Evaluation of a sequencing batch reactor sewage treatment rig for investigating the fate of radioactively labelled pharmaceuticals : case study of propranolol
- Submitting institution
-
University of Portsmouth
- Unit of assessment
- 12 - Engineering
- Output identifier
- 7126228
- Type
- D - Journal article
- DOI
-
10.1016/j.watres.2015.09.033
- Title of journal
- Water Research
- Article number
- -
- First page
- 83
- Volume
- 88
- Issue
- -
- ISSN
- 0043-1354
- Open access status
- Out of scope for open access requirements
- Month of publication
- September
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
4
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- An EPSRC CASE award with AstraZeneca (EP/G501688/1) examined pharmaceutical fates during wastewater treatment to elucidate removal mechanisms (e.g. sorption, biodegradation, effluent) and inform environmental risk assessments. This paper is significant as it validates a novel laboratory simulation of technology with aerobic/anoxic phases, uses radioactive partitioning to resolve ambiguous field monitoring findings for a common drug and highlights potential pharmaceutical accumulations in SBR sludge. These findings have influenced studies by Kolecka et al., Bioresour. Technol. 318, 124068 (2020), Brown et al., Environ. Pollut, 265,114852 (2020) and de Wilt et al., Chemosphere 193, 811-819 (2018).
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -